Registry-listed formulations

hecolin · mesh:C577000

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

2 source entries across 2 studies. This list may not include all unresolved or historical entries.

  • hepatitis E vaccineRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • HEV vaccineRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Phase 4
2
50%
Phase 3
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (50.0%)
Phase 42 (50.0%)

Trials by Status

unknown125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_4

Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh.

NCT02759991
unknownphase_4

Immunogenicity and Safety of Co-immunization With Cecolin and Hecolin

NCT05415345
completedphase_3

Clinical Trial of Recombinant Hepatitis E Vaccine

NCT01014845
completedphase_3

Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine

NCT01735006

Clinical Trials (4)

Showing 4 of 4 trials
NCT02759991Phase 4

Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh.

Completed
NCT05415345Phase 4

Immunogenicity and Safety of Co-immunization With Cecolin and Hecolin

Unknown
NCT01014845Phase 3

Clinical Trial of Recombinant Hepatitis E Vaccine

Completed
NCT01735006Phase 3

Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine

Completed

All 4 trials loaded

Drug Details

Intervention Type
Varies by study
Total Trials
4

Names & Codes

Research Codes

HEV 239